Helix Therapeutics
About:
Helix Therapeutics developed DNA-based therapeutics for the treatment of HIV/AIDS and common genetic diseases.
Website: http://helixtherapeutics.com
Top Investors: Connecticut Innovations, Canaan Partners, LaunchCapital
Description:
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.
Total Funding Amount:
$3.36M
Headquarters Location:
New Haven, Connecticut, United States
Founded Date:
2006-01-01
Contact Email:
info(AT)helixtherapeutics.com
Founders:
Peter M. Glazer, Ranjit S. Bindra
Number of Employees:
1-10
Last Funding Date:
2010-11-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai